|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
DK0495421T3
(da)
|
1991-01-15 |
1996-12-09 |
Alcon Lab Inc |
Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
|
PT700521E
(pt)
|
1993-05-28 |
2003-10-31 |
Baylor College Medicine |
Metodo e espectrometro de massa para dessorcao e ionizacao de analitos
|
|
GB9717926D0
(en)
|
1997-08-22 |
1997-10-29 |
Micromass Ltd |
Methods and apparatus for tandem mass spectrometry
|
|
JP2002502086A
(ja)
|
1998-01-23 |
2002-01-22 |
アナリティカ オブ ブランフォード インコーポレーテッド |
表面からの質量分光測定
|
|
GB0031103D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7259175B2
(en)
|
2002-02-25 |
2007-08-21 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
WO2003072100A1
(en)
|
2002-02-25 |
2003-09-04 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
EP1581491A1
(en)
|
2003-01-06 |
2005-10-05 |
Eli Lilly And Company |
Indole derivatives as ppar modulators
|
|
WO2007039171A1
(en)
|
2005-10-06 |
2007-04-12 |
Sanofi-Aventis |
4-oxy-n-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
|
|
US8552174B2
(en)
|
2005-10-31 |
2013-10-08 |
Agilent Technologies, Inc. |
Solutions, methods, and processes for deprotection of polynucleotides
|
|
DE102006056740A1
(de)
|
2006-12-01 |
2008-06-05 |
Bayer Healthcare Ag |
Cyclisch substituierte 3,5-Dicyano-2-thiopyridine und ihre Verwendung
|
|
US8093245B2
(en)
|
2006-12-14 |
2012-01-10 |
Lexicon Pharmaceuticals, Inc. |
4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use
|
|
US8093246B2
(en)
|
2006-12-14 |
2012-01-10 |
Lexicon Pharmaceuticals, Inc. |
O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer
|
|
AU2008302703B2
(en)
|
2007-09-19 |
2013-11-07 |
The Regents Of The University Of California |
Positron emission tomography probes for imaging immune activation and selected cancers
|
|
US8022216B2
(en)
*
|
2007-10-17 |
2011-09-20 |
Wyeth Llc |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
|
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
UA107791C2
(en)
|
2009-05-05 |
2015-02-25 |
Dow Agrosciences Llc |
Pesticidal compositions
|
|
ES2607806T5
(es)
*
|
2010-02-12 |
2024-10-07 |
Pfizer |
Sales y polimorfos de 8-fluoro-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-cd]indol-6-ona
|
|
WO2012122368A1
(en)
|
2011-03-08 |
2012-09-13 |
The Regents Of The University Of California |
Deoxycytidine kinase binding compounds
|
|
AU2012315384B2
(en)
|
2011-09-30 |
2017-08-10 |
Vertex Pharmaceuticals Incorporated |
Treating pancreatic cancer and non-small cell lung cancer with ATR inhibitors
|
|
JP6542216B2
(ja)
|
2013-08-13 |
2019-07-10 |
ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア |
デオキシシチジンキナーゼ阻害因子
|
|
TR201902875T4
(tr)
*
|
2013-10-18 |
2019-03-21 |
Univ Health Network |
Plk-4 inhibitörünün tuz ve kristal formları.
|
|
CN105367552A
(zh)
*
|
2015-01-09 |
2016-03-02 |
苏州晶云药物科技有限公司 |
来那替尼马来酸盐的新晶型及其制备方法
|
|
WO2016130581A2
(en)
|
2015-02-09 |
2016-08-18 |
The Regents Of The University Of California |
Combination cancer therapy
|
|
WO2016130562A2
(en)
|
2015-02-09 |
2016-08-18 |
The Regents Of The University Of California |
Metabolic analysis of the nucleotide de novo and salvage pathways
|
|
US10570124B2
(en)
*
|
2016-01-08 |
2020-02-25 |
The Regents Of The University Of California |
Deoxycytidine kinase binding compounds
|
|
US20210267885A1
(en)
|
2016-05-25 |
2021-09-02 |
Singapore Health Services Ptel Ltd |
Atropine-containing aqueous composition
|
|
KR102736865B1
(ko)
*
|
2017-06-21 |
2024-12-03 |
샤이 테라퓨틱스 엘엘씨 |
암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물
|
|
WO2019165073A1
(en)
*
|
2018-02-21 |
2019-08-29 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
|
PE20231656A1
(es)
|
2020-11-02 |
2023-10-17 |
Trethera Corp |
Formas cristalinas de un inhibidor de cinasa de desoxicitidina y sus usos
|